Bioengineering,
Год журнала:
2024,
Номер
12(1), С. 6 - 6
Опубликована: Дек. 25, 2024
Glaucoma,
a
progressive
and
multifactorial
optic
neurodegenerative
disease,
still
poses
significant
challenges
in
both
diagnosis
management
remains
perpetual
enigma
[...].
Heliyon,
Год журнала:
2024,
Номер
10(15), С. e35516 - e35516
Опубликована: Авг. 1, 2024
Glaucoma,
a
leading
cause
of
irreversible
blindness
worldwide,
is
characterized
by
progressive
loss
retinal
ganglion
cells
(RGCs)
and
optic
nerve
damage.
While
elevated
intraocular
pressure
(IOP)
the
only
known
modifiable
risk
factor,
normal-tension
glaucoma
(NTG)
challenges
this
notion,
suggesting
other
mechanisms
beyond
IOP
may
contribute
to
its
development.
Emerging
evidence
support
hypothesis
that
be
an
autoimmune
disease.
This
review
summarizes
for
hypothesis,
focusing
on
gut-retina
axis.
We
discuss
how
antigens
gut
bacterial
prime
peripheral
T
breach
blood-retina
barrier
(BRB)
initiate
cross-reactivity
with
ocular
tissues
via
molecular
mimicry,
resulting
in
RGC
Understanding
these
uncover
new
diagnostic
biomarkers
therapeutic
strategies
targeting
immune
pathways
alongside
conventional
IOP-lowering
treatments.
Frontiers in Bioscience-Landmark,
Год журнала:
2024,
Номер
29(8)
Опубликована: Авг. 23, 2024
This
review
explores
the
connection
between
ocular
surface
microbiome
and
glaucoma,
highlighting
its
impact
on
disease
progression.
Beginning
with
an
overview
of
global
glaucoma
significance,
it
emphasizes
importance
understanding
cellular
characteristics
microbiology
microbiome.
A
search
was
conducted
PubMed
Cochrane
Library
databases
using
phrase
"ocular
glaucoma".
0
records
were
returned
from
while
21
PubMed.
total
results
retrieved
2017
to
2024.
comprised
one
opinion
paper,
four
original
research
articles,
16
reviews.
covered
anatomy
surface,
advanced
analysis
methods,
It
also
delved
into
dysbiosis
in
addressing
altered
microbial
communities
their
potential
role
The
intricate
interplay
host's
immune
system
is
explored,
emphasizing
crosstalk
inflammatory
responses.
concludes
by
discussing
therapeutic
implications,
including
modulating
microbiota
future
treatment
strategies.
Understanding
healthy
glaucomatous
eyes
can
help
researchers
clinicians
innovative
approaches
health.
Clinical and Experimental Ophthalmology,
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 26, 2024
Abstract
Background
Glaucoma
is
the
most
common
cause
of
irreversible
blindness,
and
gut
microbiota
(GM)
associated
with
glaucoma.
Whether
this
association
represents
a
causal
role
remains
unknown.
This
study
aims
to
assess
potential
link
between
GM
various
forms
glaucoma,
emphasising
need
for
cautious
interpretation
strength
these
associations.
Methods
Employing
two‐sample
bidirectional
Mendelian
randomisation
(MR)
framework
false
discovery
rate
correction
sensitivity
analyses,
supplemented
by
genetic
correlation
analysis
via
linkage
disequilibrium
score
regression
(LDSC)
colocalisation
European
summary‐level
data
MiBioGen
consortium
FinnGen
Study,
we
sought
explore
relationship
Results
While
certain
microbial
taxa
showed
associations
glaucoma
subtypes
(e.g.,
Erysipelotrichaceae
primary
angle
closure
Senegalimassilia
exfoliation
glaucoma),
overall
findings
suggest
complex
not
definitively
Notably,
reverse
MR
did
establish
significant
effect
on
composition,
no
consistent
correlations
were
observed
Conclusions
our
provides
some
evidence
specific
results
underscore
complexity
relationships
further
research
clarify
links.
The
highlight
importance
interpreting
gut‐eye
axis
caution
that
while
may
play
in
it
unlikely
be
predominant
factor.
Russian Ophthalmological Journal,
Год журнала:
2024,
Номер
17(2), С. 148 - 153
Опубликована: Июль 2, 2024
Nowadays,
glaucoma
is
viewed
as
a
multifactorial
neurodegenerative
condition
that
involves
many
factors
affecting
different
cell
types
in
human
body.
As
known,
increased
intraocular
pressure
(IOP)
not
the
only
threatening
factor
of
ganglion
apoptosis
and
glaucomatous
optic
neuropathy
development;
IOP
can
be
associated
with
other
factors,
such
vascular,
metabolic,
neurotrophic,
immune,
inflammatory,
etc.
However,
treatment
remains
largely
symptomatic,
aimed
almost
exclusively
at
reducing
IOP.
Microbiotic
dysbiosis
newly
developing
research
direction
progress,
showing
this
mechanism
may
turn
out
to
an
important
development.
There
are
reasons
believe
strategies
microbiota
damage
correction
contribute
better
efficiency
management.
The
gut
microbiome
has
been
studied
in
recent
years
due
to
its
association
with
various
pathological
pathways
involved
different
diseases,
caused
by
structure,
function,
and
diversity
alteration.
knowledge
of
this
mechanism
generated
interest
the
investigation
relationship
ophthalmologic
diseases.
Recent
studies
infer
existence
a
gut-eye
microbiota
axis,
influenced
intestinal
barrier,
blood-retina
immune
privilege
eye.
A
common
denominator
among
diseases
that
have
related
axis
is
inflammation,
which
perpetuated
dysbiosis,
causing
an
alteration
barrier
leading
increased
permeability
and,
turn,
release
components
such
as
lipopolysaccharides
(LPS),
trimethylamine
oxide
(TMAO),
bacterial
translocation.
Some
theories
explain
depending
on
how
composed,
type
T
cells
will
be
activated,
while
others
say
some
bacteria
can
pre-activate
mimic
ocular
structures
allow
leakage
metabolites
into
circulation.
In
addition,
therapies
probiotics,
diet,
fecal
transplantation
(FMT)
shown
favor
presence
balanced
population
microorganisms
limit
inflammation
generate
beneficial
effect
these
eye
pathologies.
This
review
aims
analyze
influences
pathologies
based
microbial
composition
mechanisms,
may
provide
better
understanding
their
therapeutic
potential.
Current Research in Microbial Sciences,
Год журнала:
2024,
Номер
7, С. 100314 - 100314
Опубликована: Янв. 1, 2024
Glaucoma
is
the
primary
cause
of
irreversible
blindness
globally.
Different
glaucoma
subtypes
are
identified
by
their
underlying
mechanisms,
and
treatment
options
differ
its
pathogenesis.
Current
management
includes
topical
medications
to
lower
intraocular
pressure
surgical
procedures
like
trabeculoplasty
drainage
implants.
Fecal
microbiota
transplantation
(FMT)
an
almost
effective
safe
option
for
recurrent
Clostridium
difficile
infection.
The
relationship
between
bacterial
populations,
metabolites,
inflammatory
pathways
in
retinal
diseases
indicates
possible
therapeutic
strategies.
Thus,
incorporating
host
microbiota-based
therapies
could
offer
additional
patients.
Here,
we
propose
that
combining
FMT
with
standard
treatments
may
benefit
those
affected
this
condition.
Also,
potential
safety,
efficacy,
cost-effectiveness
clinical
applications
discussed.
Bioengineering,
Год журнала:
2024,
Номер
12(1), С. 6 - 6
Опубликована: Дек. 25, 2024
Glaucoma,
a
progressive
and
multifactorial
optic
neurodegenerative
disease,
still
poses
significant
challenges
in
both
diagnosis
management
remains
perpetual
enigma
[...].